Dog Microbiome – Impact on Health and Wellbeing

Gut Microbiome – Impacts on Key Areas of Health for Dogs

Summary

The gut microbiome is a complex and dynamic ecosystem within dogs that plays a significant role in their overall health and wellbeing. This intricate community of microorganisms influences various bodily systems, from the gastrointestinal tract to the brain, heart, and immune system. Understanding the microbiome’s impact on health has opened new avenues for treating and preventing chronic diseases in dogs. This article explores the profound connections between the gut microbiome and different aspects of canine health, highlighting current research findings and potential therapeutic strategies.

Table of Contents

Introduction

The Role of the Gut Microbiome in Systemic Health

• Gut Microbiome Overview
• Influence on General Wellbeing

Influence of the Microbiome on Gastrointestinal Health

• Diarrhoea and Microbial Dysbiosis
• Bile Acid Dysregulation
• Impact of Antibiotics
• Microbiota-Targeted Treatments

Influence of the Gut Microbiome on Behavioural Health

• Gut-Brain Axis and Behavioural Implications
• Microbial Influence on Aggression and Phobia
• Impact on Memory and Cognitive Function
• Microbiome-Targeted Interventions for Behavioural Issues

Influence of the Gut Microbiome on Cardiovascular Health

• Role of Microbial Metabolites in Heart Disease
• Trimethylamine N-Oxide (TMAO) and Myxomatous Mitral Valve Disease (MMVD)
• Short-Chain Fatty Acids (SCFA) and Cardiac Function

Influence of the Gut Microbiome on Immune Health

• Interaction Between Gut Microbiome and Immune System
• Inflammatory Bowel Disease (IBD) and Immune Dysregulation
• Probiotics and Immune Modulation
• Stress-Induced Immune Responses

Conclusion

• Summary of Findings
• Future Directions and Research Needs

Introduction

In recent years, the bond between humans and their canine companions has grown closer, with pets becoming integral members of households. This shift has also led to an increased focus on the health of pets, particularly as dogs now share many of the same chronic diseases as their human owners. The gut microbiome, a complex community of microorganisms residing in the gastrointestinal tract, is at the forefront of this research due to its significant impact on various aspects of health.

The gut microbiome is not only a key player in digestion but also influences a range of physiological processes, including immune function, behaviour, and cardiovascular health. The balance of microbial species within the gut is crucial for maintaining health, and disruptions to this balance—referred to as dysbiosis—are linked to numerous chronic diseases. This article provides an in-depth exploration of the gut microbiome’s role in canine health, examining its influence on gastrointestinal, behavioural, cardiovascular, and immune systems.

The Role of the Gut Microbiome in Systemic Health

Gut Microbiome Overview

The gut microbiome is a diverse and dynamic ecosystem composed of bacteria, viruses, fungi, and other microorganisms that inhabit the gastrointestinal tract. These microorganisms play a critical role in maintaining health by aiding in digestion, synthesising essential nutrients, and protecting against harmful pathogens. The composition of the gut microbiome is influenced by various factors, including diet, age, genetics, and environmental exposures.

In dogs, as in humans, the gut microbiome is highly individualised, meaning that no two dogs have the exact same microbial composition. This uniqueness is shaped by a combination of factors such as diet, medication use, and even the environment in which the dog lives. A healthy gut microbiome is typically characterised by a high level of diversity, which provides resilience against disruptions and helps maintain a balanced ecosystem within the gut.

Influence on General Wellbeing

The gut microbiome’s influence extends beyond the gastrointestinal tract, affecting multiple aspects of overall health. A diverse and balanced microbiome supports metabolic functions, regulates immune responses, and even communicates with the brain via the gut-brain axis. Dysbiosis, or an imbalance in the microbiome, can lead to various health issues, including gastrointestinal disorders, systemic inflammation, and behavioural changes.

Research has shown that dogs with a more diverse gut microbiome are generally healthier and more resilient to diseases. Conversely, a less diverse microbiome is often associated with an increased risk of chronic diseases, such as inflammatory bowel disease (IBD) and cardiovascular conditions. Understanding the intricate relationships between the gut microbiome and overall health is essential for developing targeted therapies that can restore or maintain microbial balance.

Influence of the Microbiome on Gastrointestinal Health

Diarrhoea and Microbial Dysbiosis

Diarrhoea is one of the most common reasons for veterinary visits in dogs, and it is often linked to dysbiosis. The gut microbiome plays a crucial role in maintaining gastrointestinal health, and disruptions to this balance can lead to diarrhoea and other digestive issues. Several factors can contribute to dysbiosis, including infections, diet changes, and the use of antibiotics.

The presence of certain bacterial species, such as Clostridium difficile, has been strongly associated with severe diarrhoea in dogs. This pathogen can overgrow in the gut, particularly when the balance of the microbiome is disrupted, leading to significant gastrointestinal distress. On the other hand, beneficial bacteria like Clostridium hiranonis play a protective role by converting primary bile acids into secondary bile acids, which are essential for gut health. When the levels of these beneficial bacteria are reduced, it can lead to bile acid dysregulation, contributing to diarrhoea.

Bile Acid Dysregulation

Bile acids are critical for the digestion and absorption of fats, and their metabolism is heavily influenced by the gut microbiome. In dogs, bile acids are produced by the liver and then modified by gut bacteria into secondary bile acids. These secondary bile acids play a role in regulating gut motility and maintaining the integrity of the gut lining.

In cases of dysbiosis, the production and metabolism of bile acids can become dysregulated. For example, in dogs with chronic enteropathy (a condition similar to IBD in humans), there is often a decrease in the abundance of bile acid-metabolising bacteria such as Clostridium hiranonis. This reduction leads to an imbalance in bile acid metabolism, which can exacerbate gastrointestinal symptoms such as diarrhoea. Therapeutic strategies that aim to restore the balance of bile acid-metabolising bacteria are being explored as potential treatments for conditions like chronic enteropathy.

Impact of Antibiotics

Antibiotics are commonly prescribed to treat bacterial infections in dogs, but their impact on the gut microbiome can be profound. While antibiotics can be life-saving, they also disrupt the balance of the gut microbiome, leading to a reduction in beneficial bacteria and allowing pathogenic species to proliferate. This disruption can result in antibiotic-associated gastrointestinal symptoms (AAGS), such as diarrhoea, vomiting, and anorexia.

Studies have shown that the use of antibiotics can significantly alter the gut microbiome, with effects that can persist long after the treatment has ended. For example, a study found that dogs treated with the antibiotic tylosin experienced elevated levels of primary bile acids for two months after treatment, indicating long-term disruption of bile acid metabolism. Additionally, antibiotics have been shown to reduce the abundance of Clostridium hiranonis, a key player in maintaining bile acid balance, further exacerbating gastrointestinal symptoms.

Given these risks, it is important to use antibiotics judiciously and consider alternative treatments that support the microbiome, such as probiotics or faecal microbiota transplantation (FMT).

Microbiota-Targeted Treatments

As understanding of the gut microbiome’s role in health deepens, new treatment strategies that target the microbiome are emerging. These include probiotics, prebiotics, synbiotics, and faecal microbiota transplantation (FMT). Probiotics are live microorganisms that can confer health benefits by restoring balance to the gut microbiome, while prebiotics are dietary fibres that feed beneficial bacteria. Synbiotics combine both probiotics and prebiotics to enhance their effects.

FMT is a more direct approach, involving the transfer of faecal microbiota from a healthy donor to a recipient with dysbiosis. This procedure has shown promise in treating conditions like chronic diarrhoea and Clostridium difficile infections in both humans and dogs. Although still experimental, FMT represents a potential breakthrough in microbiome-targeted therapies.

Influence of the Gut Microbiome on Behavioural Health

Gut-Brain Axis and Behavioural Implications

The gut-brain axis is a bidirectional communication pathway between the gut and the brain, mediated by the nervous system, hormones, and the immune system. This connection plays a significant role in regulating mood, behaviour, and cognitive functions in dogs. Recent research has shown that the gut microbiome can influence the brain and behaviour through the production of neurotransmitters, modulation of the immune system, and interaction with the central nervous system.

For example, certain gut bacteria are involved in the production of gamma-aminobutyric acid (GABA), an inhibitory neurotransmitter that helps regulate anxiety and stress responses. Disruptions in the gut microbiome can alter the levels of these neurotransmitters, potentially leading to behavioural changes such as increased anxiety, aggression, or depression.

Microbial Influence on Aggression and Phobia

Behavioural issues such as aggression and phobias are common in dogs and can be challenging to manage. Research suggests that the gut microbiome may play a role in these behaviours by influencing the production of hormones and neurotransmitters. For instance, studies have found that phobic dogs have higher levels of Lactobacillus species, which are known to produce GABA and modulate immune function. On the other hand, aggressive dogs have been found to have higher levels of Turicibacter species, which are responsive to the neurotransmitter serotonin.

These findings indicate that imbalances in the gut microbiome could contribute to behavioural problems. However, the relationship between specific microbial species and behaviour is complex, with conflicting results reported in different studies. This highlights the need for more research to understand the mechanisms by which the microbiome influences behaviour and to develop effective interventions.

Impact on Memory and Cognitive Function

Memory and cognitive function are essential for dogs to learn, adapt, and interact with their environment. Emerging research suggests that the gut microbiome may influence cognitive functions through its impact on brain health. For example, dogs with poorer memory test performances have been found to have higher levels of Actinobacteria, a phylum of bacteria associated with neurodegenerative conditions in humans.

While the exact mechanisms are not yet fully understood, it is believed that microbial metabolites produced in the gut can influence brain function and cognitive processes. These findings open up the possibility of using microbiome-targeted therapies to support cognitive health in dogs, particularly as they age.

Microbiome-Targeted Interventions for Behavioural Issues

Given the growing evidence of the gut-brain axis’s influence on behaviour, researchers are exploring microbiome-targeted interventions as a way to address behavioural issues in dogs. Probiotics, prebiotics, and synbiotics are being studied for their potential to improve behaviour by modulating the gut microbiome.

For instance, certain probiotic strains have been shown to reduce anxiety and stress in dogs, potentially by enhancing the production of GABA or reducing inflammation. Similarly, dietary interventions that promote a healthy gut microbiome may help mitigate behavioural issues related to aggression, anxiety, and cognitive decline.

Influence of the Gut Microbiome on Cardiovascular Health

Role of Microbial Metabolites in Heart Disease

Cardiovascular diseases, such as myxomatous mitral valve disease (MMVD), are a leading cause of morbidity and mortality in dogs, particularly as they age. Recent research has highlighted the role of microbial metabolites in the development and progression of heart disease. These metabolites, produced by the gut microbiome, can influence various aspects of cardiovascular health, including energy metabolism and inflammation.

For example, trimethylamine N-oxide (TMAO), a metabolite produced from the microbial metabolism of dietary compounds like carnitine and choline, has been linked to the severity of MMVD in dogs. High levels of TMAO are associated with increased risk of heart disease, making it a potential target for therapeutic interventions.

Trimethylamine N-Oxide (TMAO) and Myxomatous Mitral Valve Disease (MMVD)

TMAO is a by-product of the microbial metabolism of nitrogenous compounds found in foods like meat, dairy, fish, and eggs. Once produced in the gut, TMAO enters the bloodstream, where it has been shown to contribute to the progression of cardiovascular diseases, including MMVD.

In dogs with MMVD, elevated levels of TMAO are associated with more severe disease progression. Research suggests that reducing the intake of TMAO precursors, such as carnitine and choline, could help manage the condition by limiting the production of this harmful metabolite. Additionally, targeting the gut microbiome to reduce the abundance of TMA-producing bacteria, such as Escherichia coli, is another potential strategy for mitigating the impact of TMAO on heart health.

Short-Chain Fatty Acids (SCFA) and Cardiac Function

Short-chain fatty acids (SCFAs) are beneficial metabolites produced by the fermentation of dietary fibres by gut bacteria. SCFAs play a crucial role in regulating energy metabolism, reducing inflammation, and supporting overall cardiovascular health. In dogs with MMVD, lower levels of SCFA-producing bacteria have been observed, which may contribute to the progression of the disease.

While the exact role of SCFAs in heart health is still being studied, increasing the abundance of SCFA-producing bacteria through dietary interventions could offer a potential therapeutic approach for managing MMVD. This could be achieved by promoting a diet rich in fibre, which supports the growth of beneficial gut bacteria that produce SCFAs.

Influence of the Gut Microbiome on Immune Health

Interaction Between Gut Microbiome and Immune System

The gut microbiome is a key player in the regulation of the immune system, influencing both local gut immunity and systemic immune responses. The immune system constantly monitors the gut environment, distinguishing between harmless commensal bacteria and potential pathogens. Dysbiosis can disrupt this balance, leading to immune dysregulation and the development of chronic inflammatory conditions such as inflammatory bowel disease (IBD).

In dogs, IBD is characterised by chronic inflammation of the gastrointestinal tract, often associated with an overactive immune response against gut microbes. This condition is linked to significant alterations in the gut microbiome, with a reduction in beneficial bacteria and an increase in pathogenic species. Restoring balance to the gut microbiome through dietary interventions, probiotics, or other therapies is being explored as a way to manage IBD and other immune-related conditions.

Inflammatory Bowel Disease (IBD) and Immune Dysregulation

IBD is a complex and multifactorial disease that affects both humans and dogs. In dogs, IBD is often characterised by chronic diarrhoea, vomiting, weight loss, and abdominal pain. The exact cause of IBD is not fully understood, but it is believed to involve an interplay between genetic predisposition, environmental factors, and dysbiosis.

Dogs with IBD typically exhibit an overactive immune response to gut microbes, leading to chronic inflammation and tissue damage. This immune dysregulation is often accompanied by significant changes in the gut microbiome, including a decrease in beneficial bacteria and an increase in harmful species. Probiotics, prebiotics, and dietary interventions that promote a balanced microbiome are being investigated as potential treatments for IBD, with the goal of reducing inflammation and restoring gut health.

Probiotics and Immune Modulation

Probiotics have shown promise in modulating the immune system and reducing inflammation in dogs with IBD. Certain strains of probiotics can enhance the production of anti-inflammatory compounds and support a healthy immune response. For example, the multi-strain probiotic Slab51 has been shown to have anti-inflammatory effects in dogs with IBD, potentially by promoting the growth of beneficial bacteria and reducing the abundance of harmful species.

In addition to live probiotics, postbiotics—cell wall extracts from probiotic bacteria—have also demonstrated immune-modulating properties. Studies have shown that postbiotics can reduce the production of pro-inflammatory cytokines and support gut health, making them a potential therapeutic option for managing IBD and other inflammatory conditions.

Stress-Induced Immune Responses

Stress is a common trigger for immune dysregulation and can exacerbate conditions like IBD. For example, transportation stress in cats has been shown to induce IBD-like symptoms, including diarrhoea, immune activation, and increased intestinal permeability. This stress-induced dysbiosis can lead to an overgrowth of pro-inflammatory microbes, further exacerbating gut inflammation.

Antimicrobial peptides (AMPs) are emerging as a potential treatment for stress-induced gut inflammation. AMPs can reduce the abundance of pro-inflammatory microbes while promoting the growth of beneficial species that produce short-chain fatty acids (SCFAs) and have anti-inflammatory effects. This approach offers a promising avenue for managing stress-related gut issues in both dogs and cats.

Conclusion

The gut microbiome plays a critical role in modulating various aspects of canine health, from gastrointestinal and behavioural health to cardiovascular and immune functions. This article has explored the complex interactions between the gut microbiome and these different systems, highlighting the potential for microbiome-targeted therapies to prevent and treat chronic diseases in dogs.

While our understanding of the gut microbiome’s influence on health is still evolving, the research presented here underscores the importance of maintaining a balanced and diverse microbiome. Future research should focus on personalising these interventions to account for individual differences in the microbiome and exploring their applicability across different species. As our knowledge expands, the gut microbiome may become a central focus in the prevention and treatment of chronic diseases in dogs, offering new hope for improving their health and wellbeing.

Table 1: Overview of the Role of the Gut Microbiome on Canine Health

Bonza Superfoods and Ancient Grains, a premium plant-based dog food, was developed in conjunction with vets, canine nutritionists and canine herbalists.

The formula adapts a ‘Food as Medicine‘ approach to dog nutrition, using clinically researched and science informed, ingredients to provide preventative health support for the most prevalent conditions dogs suffer from including chronic diseases such as cancers, immune mediated diseases IBD, diabetes, osteoarthritis and rheumatoid arthritis as well as skin conditions and digestive issues.

Understanding the key role the gut-brain axis plays in a multitude areas of dog health, supporting a healthy microbiome and Eubiosis was of paramount importance in formulating the food.

This high quality vegan dog food includes the following ingredients and nutraceuticals known to impact the microbiome and in turn a dog’s best health:

• Prebiotics (including Inulin, MOS and FOS, Baobab and Yucca Schidigera)
• Probiotics – Calsporin®
• Postbiotics – TruPet™
• Omega-3 – DHAgold®
• Medicinal Herbs (to improve gut health and reduce stress and anxiety)
• Adaptogens (to provide non-specific system support and reduce stress)

Our objective to create the best food for the healthiest dog microbiome and all the benefits this confers on our dogs for living their longest, healthiest lives.